Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Novel Laboratories (Rights to Generic Version of HalfLytely)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Pharmaceutical rights of Tablets. It contains rights for preparation of tablets for the cleansing of the colon as a preparation for colonoscopy in adults.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Acquirer
Primary Office
  • 400 Campus Drive
  • Somerset, NJ
  • United States

Novel Laboratories (Rights to Generic Version of HalfLytely) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Novel Laboratories (Rights to Generic Version of HalfLytely)‘s full profile, request access.

Request full access to PitchBook

Novel Laboratories (Rights to Generic Version of HalfLytely) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Novel Laboratories (Rights to Generic Version of HalfLytely)‘s full profile, request access.

Request full access to PitchBook